Exhibit 99.1
InfuSystem Holdings, Inc.
Post Shareholders Meeting
August 29, 2013
Eric K. Steen, CEO
Jonathan P. Foster, CFO
InfuSystem®
INFUSION MADE EASY SM
Safe Harbor Statement
Certain statements contained in this release are forward-looking statements and are based on future expectations, plans and prospects for InfuSystem Holdings, Inc.’s (“InfuSystem”, “INFU”, “the Company”, “We”) business and operations that involve a number of risks and uncertainties. InfuSystem’s outlook for 2013 and other forward-looking statements in this release are made as of August 29, 2013, and the Company disclaims any duty to supplement, update or revise such statements on a going-forward basis, whether as a result of subsequent developments, changed expectations or otherwise. In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, the Company is identifying certain factors that could cause actual results to differ, perhaps materially, from those indicated by these forward-looking statements. Those factors, risks and uncertainties include, but are not limited to, potential changes in overall healthcare reimbursement - including CMS competitive bidding, sequestration, concentration of customers, increased focus on early detection of cancer, competitive treatments, dependency on Medicare Supplier Number, availability of chemotherapy drugs, global financial conditions, changes and enforcement of state and federal laws, natural forces, competition, dependency on suppliers, risks in acquisitions & joint ventures, US Healthcare Reform, relationships with healthcare professionals and organizations, technological changes related to infusion therapy, dependency on websites and intellectual property, the ability of the Company to successfully integrate acquired businesses, dependency on key personnel, dependency on banking relations and covenants, and other risks associated with our common stock, as well as any other litigation to which the Company may be subject from time to time; and other risk factors as discussed in the Company’s annual report on Form
10-K for the year ended December 31, 2012 and in other filings made by the Company from time to time with the Securities and Exchange Commission.
InfuSystem®
INFUSION MADE EASY SM
Positioned for Growth
InfuSystem®
INFUSION MADE EASY SM
Positioned For Growth
Market Trends
InfuSystem is uniquely positioned to take advantage of market trends
Strategy
Transformational strategy is developed and being implemented
Leadership
Leadership can now focus on running a business for first time in over a year
InfuSystem®
INFUSION MADE EASY SM
InfuSystem Patient Population is Extension of Infusion Therapy From Clinic to Home
Discharge Planner
HIT HHA DME IHSHC
Home Infusion
InfuSystem
InfuSystem®
INFUSION MADE EASY SM
Extension of Clinic to Home
Ambulatory Infusion
Some drugs more effective when infused continuously
Patient Satisfaction
Multiple Therapies - Oncology, Post Surgical Pain, Special Disease States
Payor Contracts
Over 250 Payor Contracts
Private Pay & Government
Commercial Payors reimburse more therapies than CMS
InfuSystem®
INFUSION MADE EASY SM
Population Growth, Age and Growth of Cancers
Population Stats
Aging Population
At-risk lifestyles persist (red, processed meats).
Colo-rectal
3rd most common in US and Worldwide
U.S. Population
316,518,80
InfuSystem®
INFUSION MADE EASY SM
Infu Oncology Patients
Esophogeal
Head and Neck
Pancreas
Stomach
Colo-Rectal
* A.D.A.M. Medical Encyclopedia
CR Contrib. Factors*
Are older than 60
Eat a lot of red or processed meats
Have colo-rectal polyps
Have a family history of colon cancer
Have a personal history of breast cancer
Smoking and Alcohol
InfuSystem®
INFUSION MADE EASY SM
InfuSystem Cancer Patients
450%
400%
350%
300%
250%
200%
150%
100%
50%
0%
Pancreas 343%
Esophogeal
Head and Neck 4%
InfuSystem Patient Statistics
CR Grew by 16%
Pancreatic +343%
Stomach 61%
Colo-Rectal 16%
InfuSystem®
INFUSION MADE EASY SM
Revenue Diversity
2009 Revenues
Rentals - Colorectal Cancer Rentals - Pain Management Sales - DP
Rentals - Other Cancers Rentals - Hospitals/Home Care
Rentals - Infectious Disease Rentals - Service & Repair
Revenue Diversity
2009 Revenues
2012 Revenues
Rentals - Colorectal Cancer Rentals - Pain Management Sales - DP
Rentals - Other Cancers Rentals - Hospitals/Home Care
Rentals - Infectious Disease Rentals - Service & Repair
Increasing Therapy Offerings to Payors
Payor
Oncology
Infectious Disease
Surgery
Special Disease States
InfuSystem®
INFUSION MADE EASY SM
Continuous Peripheral Nerve Block at Home
There are 5.69M orthopedic surgeries annual.
~50% of these patients are potential candidates for pain management with a continuous peripheral nerve block (CPNB) Growth of CPNB
Growth of CPNB at Home
HCAHPS (H CAPS): Pain Scores affect Hospital Reimbursement.
InfuSystem®
INFUSION MADE EASY SM
Total Home Infusion Market
$9B - $11B
Home Infusion Market
Home Infusion
Lower cost than clinical setting
Increasing Importance to lower cost in Affordable Care Act future
Lowest cost and highest patient satisfaction site for extension of infusion therapy is the home
InfuSystem Niche
Therapy started in a clinic
Estimated over $600 Million market.
InfuSystem has 10 % of total and leading share of Oncology with 1,600 practice sites served.
InfuSystem®
INFUSION MADE EASY SM
Biomedical Rentals, Service and Repair
Pump Rentals, Asset Management and Sales
Direct Sales of Device and Supplies
Pump Broker - ability to acquire CAP EX in cost effective way
Asset Management, Rental and Lease
Preventative Maint.
Annual Pump Recertification
Preventative Maintenance
Warranty
Repair
ISO Certified Service Facilities - Recertification just passed !
Regional Distribution
28 Certified Technicians
InfuSystem®
INFUSION MADE EASY SM
Offering Infusion to All Points of Care
Provider
Home Infusion
Long Term Care
Emergency Services
Acute Care
Oncology
InfuSystem®
INFUSION MADE EASY SM
Full Line Multi-Therapy & Multi-Point Offering
InfuSystem®
INFUSION MADE EASY SM
Payor
Patient
Provider
Partners
Device & Pharma Manufacturer, Distributor, GPO, ACO
InfuSystem®
INFUSION MADE EASY SM
What a Difference a Year Makes
Financial Position
New Team in place
IT improvements begun
New Product launches - Kits, Smart Pumps, Post Surgical Pain
InfuSystem®
INFUSION MADE EASY SM
IT and Automation
Shift into High Gear
More insurance billings with existing staff
Greater revenue per employee
Road Map completed , New iPad features, Automation of initial internal processes
InfuSystem®
INFUSION MADE EASY SM
Connectivity through eMAR , Web Portal and System Interface
Bring the Pumps to the People in Large Markets
Largest Markets
#1 New York
#2 Los Angeles
#3 Houston + Dallas
#4 Atlanta + Miami
#5 Chicago
InfuSystem®
INFUSION MADE EASY SM
For Faster Turnaround and Improved Utilization
Los Angeles Area Service Center
Toronto Canada Service Center
Madison Heights Service Center
Kansas City Service Center
Future New Jersey Service Center
Future Atlanta Service Center
Opening Soon Houston Service Center
InfuSystem Distribution
New Houston Service Center
Expanded Los Angeles Area Service Center
High-density Metro Markets
Large Customers
InfuSystem®
INFUSION MADE EASY SM
Where Does This Get INFU in Three Years ?
Aging Population and Cancer growth
More Patients Home IV , commercial pay recognizing value, CMS competitive bidding
Peripheral Nerve Block and Smart Pump Growth
Revenue Growth in High Single Digits
InfuSystem®
INFUSION MADE EASY SM
Next Up - Action Items
IT Implementation - web portal, eMar, interfaces, automation of insurance processes
Product and service line expansion
Geographic Expansion
Productivity measures implemented
Evaluating depreciable life
Utilization metrics and improvement
InfuSystem®
INFUSION MADE EASY SM
Positioned For Growth
Market Trends
InfuSystem is uniquely positioned to take advantage of market trends
Strategy
Transformational strategy is developed and being implemented
Leadership
Leadership can now focus on running a business for first time in over a year
InfuSystem®
INFUSION MADE EASY SM
Financial Review
InfuSystem®
INFUSION MADE EASY SM
Ambulatory Rental Pump Fleet
n With over 26,000+ pumps in TPP Rental Fleet, InfuSystem maintains the largest fleet of ambulatory infusion pumps in the industry
n DPP Rental Fleet has over 20,000 pumps
n The Company has a complete inventory of virtually every model pump from every leading manufacturer, allowing InfuSystem to provide the right pump for any patient’s prescribed protocol
n Purchases of pumps have a high return on investment and an useful life of 10-15 years
TPP Ambulatory Pump Financial Profile
Average Cost
~$1,500/pump
Average Monthly Revenue
~$300/pump
Treatment Duration
4 - 6 months
Useful Life
10-15 years
Lifetime Revenue/Pump
Approx. ~$20,000+
Annual Rental Revenue per $1 Rental Fleet Cost (“Revenue Ratio”)
InfuSystem®
All Rentals (Both DP and TPP) -
YE 2011
YE 2012
Q1 2013
Q2 2013
Rental Revenue ($K)
$46,795
$53,471
$13,445
$13,618
Medical Equipment in Service - Cost ($K)
$31,734
$34,193
$35,026
$35,474
Rental Revenue Per Dollar of
Medical Equipment in Service Invested - Annualized
$1.47
$1.56
$1.54
$1.54
INFUSION MADE EASY SM
Competitive Bidding Overview
Competitive Bidding Overview
n InfuSystem was not involved in Round 1 nor Round 2 of Competitive Bidding
n CMS announced a Recompete of Round 1 competitive bidding on April 17th
Š External infusion pumps/supplies added as a new product category
Š A supplier must bid on all items within the product category to have its RFP considered
Š Recompete covers 9 Metropolitan Statistical Areas (MSAs)
InfuSystem’s Response to Competitive Bidding
n InfuSystem has engaged consultants and industry professionals to discuss directly with CMS, advise on positioning the Company for potential regulatory changes, and facilitate potential strategic partnership opportunities
n Competitive environment will vary in accordance with the level of cuts by CMS
CMS Competitive Bidding “Target” Timetable as of August 20, 2012
| Spring 2012 |
08/16/12 |
10/15/12 |
12/14/12 |
Summer/Fall 2013 |
12/31/13 |
01/01/14 | ||||||
| CMS began the pre-bidding supplier awareness program |
CMS announced bidding schedule, start bidder education and begin a bidder registration period to obtain user ID and password |
Bid window opens |
Bid window closes |
CMS to announce single payment amounts & contract awards |
Current Round 1 bid contracts expire |
Implementation of Round 1 bid contracts and prices |
* These dates are subject to change
CMS will institute some form of competitive bidding nationwide by January 2016.
InfuSystem®
INFUSION MADE EASY SM
Summary Income Statement
($000’s)
FY2009
FY2010
FY2011
FY2012
6 Mo 2012
6 Mo 2013
Net revenues:
Rentals
$46,795
$53,471
$25,878
$27,061
Product sales
$7,842
$5,357
$2,542
$2,302
Net revenues
$38,964
$47,229
$54,637
$58,828
$28,420
$29,363
Cost of revenues:
Product, service and supply costs
$6,200
$7,730
$9,128
$9,165
$4,383
$5,424
Pump depreciation and loss on disposal
$4,127
$5,954
$10,154
$6,752
$3,327
$3,186
Gross profit
$35,355
$42,911
$20,710
$20,753
Provision for doubtful accounts
$4,006
$4,515
$4,099
$5,251
$2,140
$2,987
Amortization of intangibles
$1,827
$2,259
$2,662
$2,734
$1,358
$1,324
Asset impairment charges
$67,592
Selling and marketing
$5,258
$7,087
$9,371
$9,864
$5,286
$4,890
General and administrative
$12,218
$20,622
$17,987
$23,062
$12,410
$10,039
Operating income (loss)
$5,328
$(938)
$(66,356)
$2,000
$(484)
$1,513
Total other (loss)
$(3,577)
$(2,285)
$(2,221)
$(4,152)
$(1,814)
$(1,462)
Loss before income taxes
$1,751
$(3,223)
$(68,577)
$(2,152)
$(2,298)
$51
Income tax benefit
$(977)
$1,371
$23,134
$663
$555
$105
Net income (loss)
$774
$(1,852)
$(45,443)
$(1,489)
$(1,743)
$156
EBITDA
$11,199
$7,745
$(57,336)
$9,590
$3,227
$5,818
EBITDA (ex. Impairment Charges)
$11,199
$7,745
$10,256
$9,590
$3,227
$5,818
Adjusted EBITDA
NA
NA
$10,256
$13,126
$6,989
$7,016
Revenue Diversity
2009 Revenues
| 0% |
1% |
0% |
2% |
|||||
| 1% |
||||||||
| 26% |
||||||||
| 70% |
Rentals - Colorectal Cancer
Rentals - Other Cancers
Rentals - Infectious Disease
Rentals - Pain Management
Rentals - Hospitals/Home Care
Rentals - Service & Repair
Sales - DP
Revenue Diversity
2009 Revenues
0% 1% 0% 2% 1% 26% 70%
2012 Revenues
4% 9% 13% 0% 0% 51% 23%
Rentals - Colorectal Cancer
Rentals - Other Cancers
Rentals - Infectious Disease
Rentals - Pain Management
Rentals - Hospitals/Home Care
Rentals - Service & Repair
Sales - DP
Summary Balance Sheet
($000’s) 12/31/09 12/31/10 12/31/11 12/31/12 3/31/13 6/30/13
ASSETS
Current Assets:
Cash and cash equivalents
$7,750 $5,014 $799 $2,326 $472 $102
Account receivable - total, net of allowance
$5,517 $6,679 $7,448 $8,511 $9,570 $9,440
Inventory
$925 $1,699 $1,309 $1,339 $1,378 $1,379
Prepaid expenses and other current assets
$395 $750 $934 $684 $832 $713
Deferred income taxes
$125 $1,147 $682 $1,971 $1,986 $1,986
Total Current Assets
$14,712 $15,289 $11,172
$14,831 $14,238 $13,620
Total PP&E and Medical Equipment
$13,499 $16,672 $17,672 $16,564 $16,653 $17,958
Deferred debt issuance costs, net
$781 $658 $421 $2,362 $2,232 $2,106
Total Goodwill and Intangible assets, net
$85,491 $97,344 $28,221 $25,541 $24,871 $24,221
Deferred income taxes
$18,187 $17,806 $17,755 $17,689
Other assets
$207 $401 $590 $419 $477 $157
Total Assets
$114,690 $130,364 $76,263 $77,523
$76,226 $75,751
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Account payable - total
$1,306 $2,016 $4,063 $2,144 $3,056 $3,833
Accrued expenses and other
$1,573 $4,631 $2,235 $4,098 $4,182 $2,782
Derivative liabilities
$2,670 $183 $258 $ - $ - $ -
Current portion of long-term debt
$5,501 $5,551 $6,576 $3,953 $3,872 $3,124
Total Current Liabilities
$11,050 $12,381 $13,132 $10,195 $11,110 $9,739
Long Term Debt, net of current portion
$18,640 $26,646 $22,551 $27,315 $24,594 $25,204
Deferred income taxes
$3,314 $5,788
Other Liabilities
$221 $406 $415 $ - $ - $ -
Total Liabilities
$33,225 $45,221 $36,098 $37,510 $35,704 $34,943
Total Stockholderrs’ Equity
$81,465 $85,143 $40,165 $40,013 $40,522 $40,808
Total Liabilities and Equity
$114,690 $130,364 $76,263 $77,523 $76,226 $75,751
Total Debt
$24,141 $32,197 $29,127 $31,268 $28,466 $28,328
Cash Flow
($000’s) FY2009 FY2010 FY2011 FY2012 6 Mo 2012 6 Mo 2013
OPERATING ACTIVITIES
Net Income
$774 $(1,852) $(45,443) $(1,489)
Adjustments:
Provision for doubtful accounts
$4,006 $4,515 $4,099 $5,251
Depreciation
$4,122 $5,357 $6,386 $5,668
Loss on disposal of pumps
$342 $994 $1,731 $237
Amortization of intangible assets
$1,827 $2,259 $2,662 $2,734
Asset impairment charges
$67,592 $ -
Stock-based compensation
$753 $3,860 $1,185 $964
Total Other Adjustments
$2,827 $(1,581) $(26,021) $(1,971)
Changes in assets and liabilities (ex. acquisitions)
$(4,943) $(2,740) $(5,445) $(5,942)
NET CASH PROVIDED BY OPERATING ACTIVITIES
$9,708 $10,812 $6,746 $5,452 $2,274 $2,233
INVESTING ACTIVITIES
Total Purchases of PP&E, Med. Eq., and Other Assets, net
$(4,611) $(2,444) $(4,502) $(2,558) $(419) $(838)
Acquisition of intangible assets
$(625) $ -
Cash paid for acquisition, net of cash acquired
$ - $(16,616)
NET CASH PROVIDED BY INVESTING ACTIVITIES
$(4,611) $(19,060) $(5,127) $(2,558) $(419) $(838)
FINANCING ACTIVITIES
Net Borrowing on term loan, revolver, and capital leases
$(8,565) $7,377 $(5,369) $1,619 $(1,818) $(3,578)
Capitalized debt issuance costs
$ - $(808) $ - $(2,842)
Common stock withholding on stock based compensation
$(135) $(167) $(102) $(144) $(32) $(41)
Treasury shares repurchased
$ - $(68) $(363) $ - $ - $ -
Principal payments on capital lease obligations
$(160) $(822)
NET CASH PROVIDED BY FINANCING ACTIVITIES
$(8,860) $5,512 $(5,834) $(1,367) $(1,850) $(3,619)
Net change in cash and cash equivalents
$(3,763) $(2,736) $(4,215) $1,527 $5 $(2,224)
Cash and cash equivalents, beginning of period
$11,513 $7,750 $5,014 $799 $799 $2,326
Cash and cash equivalents, end of period
$7,750 $5,014 $799 $2,326 $804 $102
Free Cash Flow (EBITDA less CapEx & Purchases of ME)
$6,588 $5,301 $5,754 $7,032 $2,808 $4,980
Free Cash Flow (Adj. EBITDA less CapEx & Purchases of ME)
$5,754 $10,568 $6,570 $6,178
Revenue Growth (%)
21.2% 15.7% 7.7% 3.3%
Take Away
InfuSystem®
INFUSION MADE EASY SM
Positioned For Growth
Market Trends
InfuSystem is uniquely positioned to take advantage of market trends
Strategy
Transformational strategy is developed and being implemented
Leadership
Leadership can now focus on running a business for first time in over a year
InfuSystem®
INFUSION MADE EASY SM
Thank You for Your Interest!
IR Contact Info:
The Dilenschneider Group
212-922-0900
Rob Swadosh, rswadosh@dgi-nyc.com Patrick Malone, pmalone@dgi-nyc.com
InfuSystem®
INFUSION MADE EASY SM
Appendix: INFU Overview
InfuSystem®
INFUSION MADE EASY SM
Third-Party Payor Business Overview
With a national footprint and at four times the size of its largest competitor, InfuSystem is the leading provider of ambulatory infusion pumps to oncologists and their patients
n InfuSystem provides ambulatory infusion pumps and related supplies to outpatient oncology providers, including oncology clinics and hospitals free of charge
n InfuSystem bills the patients’ health insurance providers or patients directly
n Pumps are used for the continuous infusion of chemotherapy drugs to treat colorectal and other types of cancer
n The Company offers a complete solution that benefits providers, patients and payors
Leading National Platform
Servicing all 50 States
1,600+ active healthcare facilities
“In-network” in over 250+ health plans covering approx. 222mm lives
A Complete One-Stop Solution
n Ability to provide any pump, plus related supplies at no cost to clinics
n Billing and collections directly from payors
n Maintain, clean and services equipment in-house
n 24/7 nurse-staffed patient support hotline
n Exceptional ease-of-use through iPad-based billing solutions and connectivity to major Electronic Medical Records (EMR) systems
InfuSystem®
INFUSION MADE EASY SM
Key Competitive Advantages
n “In-network” in over 250+ health plans covering approx. 222mm lives
n National footprint with over 1,600+ active healthcare facilities
n 20+ years in Durable Medical Equipment (“DME”) billing and licensing
n Full-service billing capabilities: paper, fax, electronic medical record, iPad
n Regulatory compliance in constantly changing landscape
n 24/7 support line staffed by certified oncology nurses
n Relationships with equipment manufacturers
n In-house refurbishment and repair capabilities
n Premier industry reputation for customer service
n Expansive and diverse fleet includes virtually all makes and models
InfuSystem®
INFUSION MADE EASY SM
Payor & Customer Mix
InfuSystem has strong relationships with the largest third-party payors and the leading cancer institutions
n High diversification of providers and payors
Š No single healthcare provider represents more than 7% of Third-Party Payor revenues
Š Strong payor mix among Medicare, other commercial insurers, Blue Cross/Blue Shield, and Medicaid
Š Less than 5% of revenues received directly from patients through co-pays or otherwise
n Broad coverage further diversifies revenue streams
Revenue by Payor (FY2012)
| Commercial |
Medicare and Medicaid | |
| 38% |
37% | |
| BCBS | ||
| 19% | ||
| Patient |
||
| 6% |
CMS: Centers for Medicare and Medicaid Services
Leading Cancer Institution Customers
9 of 10 of the Top Ten Cancer Treatment Centers
InfuSystem®
INFUSION MADE EASY SM
Competitive Landscape
InfuSystem measures its market share not in terms of the number of practices, but the pool of addressable patients
The breakdown of the Company’s current market share shows that despite being the predominant national player in continuous infusion, there is ample room for organic growth
The Company competes for market share in all but the Captive Health Plans which represent health plans in which all services are rendered by one common payor/provider (e.g., Kaiser Permanente)
Source: American Cancer Society, CMS, National Comprehensive Cancer Network, National Home Infusion Association
Market Share for Oncology Continuous Infusion
InfuSystem 32%
Approachable Market
Home Infusion Providers
32%
Facility Owned Pumps
11%
Competitor DME Providers
10%
Disposable
Pumps 1%
Captive Health Plan
14%
InfuSystem®
INFUSION MADE EASY SM
Direct Payor Business Model InfuSystem’s Direct Payor business is focused primarily on the sale, rental, financing and accompanying service of movable medical equipment to hospitals and alternate care sites who pay InfuSystem directly - no third-party reimbursement
Founded in 1998 and headquartered in Olathe, KS with distribution/service centers in Santa Fe Springs, CA and Mississauga, Ontario
InfuSystem services - ISO 9001 - and repairs movable medical equipment
Leading provider to alternate site healthcare facilities and hospitals in the United States and Canada
Home infusion providers, long-term care, physician clinics, research facilities, etc.
Transacts directly with healthcare providers - no third-party reimbursement revenue
Products
InfuSystem sells, rents and finances a wide variety of new and used large volume and ambulatory pumps
Infusion pumps
Syringe pumps
Enteral pumps
Ambulatory pumps
Service & Repair
InfuSystem services and repairs both its own fleet of pumps and many types of other movable medical
Large volume pumps
Fluid collection
Ambulatory pumps
Medical equipment
InfuSystem®
INFUSION MADE EASY SM
Compelling Value Proposition
Complementary core competencies allow InfuSystem to offer superior selection, flexibility, pricing and services
One-Stop Shopping Solution
One-stop shopping solution for ambulatory large volume pump and other movable medical devices
Sales
Rentals
Supplies
Service
Financing
Pre-Owned Equipment Expertise
Unique ability to source and deploy pre-owned movable medical equipment
Consistent, fair and knowledgeable market maker for pre-owned pump disposals
Market knowledge results in attractive equipment acquisition costs
“ONE-STOP SHOP”
CONVENIENCE & FLEXIBILITY
PRE-OWNED EQUIPMENT EXPERTISE
SERVICE & REPAIRS
Convenience & Flexibility
Convenience and flexibility of rentals and financing minimize customer capital outlays
Rental and financing eliminates the need for in-house maintenance/service
Option to own, rent or finance - designed to fit customers’ operating and financial parameters
Shorter and longer-term financing options
In-House Service & Repairs
World-class biomedical repair and service for pumps, defibrillators and most other general medical equipment
Allows InfuSystem to purchase, clean, repair and certify any used medical equipment the Company buys for subsequent sale, rental or financing to customers
Direct Payor Offerings
Leading Provider of New and Pre-Owned Pumps
InfuSystem offers new pumps from top brands
Broker-dealer trading desk
Web Portal
In addition, over 70 models and versions of pre-owned pumps are offered
Pre-owned pumps are re-built and certified by in-house biomedical technicians to be patient ready
Warranty offered on pre-owned pumps
A variety of financing options to fit customers’ operating, budgeting and financing parameters
Nationwide, industry-leading ISO 9001 service programs
Launching branch service center in Houston
Pre-Owned & New Pumps from Top Manufacturers
ALARIS TM MEDICAL SYSTEMS
CME Caesarea Medical Electronics
MC MarCal Medical, Inc.
sigma REDEFINING SMART
BBRAUN SHARING EXPERTISE
EXCELSIOR MEDICAL
Medis®
smiths medical
Baxter
Hospira
MOOG
CMO CRO
KENDALL HEALTHCARE PRODUCTS COMPANY
ROSS
ZEVEX®
Full Spectrum of Ownership Options for Customers
Rental
Renting new or pre-owned equipment
Rent pumps by the day, week or month to match swings in patient count
Free shipping on all rentals
Sales
Industry leader in sales of pre-owned
equipment, creating significant savings
Competitive pricing on new equipment
Option to sell back pre-owned pumps
Leasing plans offered
Asset Management
ISO 9001 Service offered
Service plans offered
Local service expansion
2 existing; 1 planned
Coordinate with TPP
Loaner pumps available
Medical Equipment Service & Repair
In addition to supporting and repairing
InfuSystem’s in-house fleet, the Company certifies, recalibrates, repairs and services a variety of infusion pumps
Pumps require scheduled maintenance and calibration in accordance with manufacturer’s specifications and regulatory guidelines
Service and repair capabilities on high demand services reaching end of life that are no longer supported by manufacturers
ISO certification and an established quality system strengthens relationships with major customers
Provides InfuSystem an opportunity to establish a business relationship with customers that acquired pumps through other sources
Continuing and increased need for compliance with current as well as anticipated regulations
28 highly qualified service technicians
5 major manufacturer relationships:
BBRAUN SHARING EXPERTISE
CMEAmerica
smiths medical
MOOG
Walkmed Infusion
3 service centers, located in California, Toronto and Kansas
InfuSystem®
INFUSION MADE EASY SM